XML 115 R39.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Segment Reporting and Foreign Operations (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Segment Reporting [Abstract] |
Schedule of Long-lived Assets by Geographic Area | Our long-lived assets (which are comprised of our net property and equipment) by geographic area at December 31, 2023, 2022 and 2021, consisted of the following (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | 2023 |  | 2022 |  | 2021
United States | ​ | $ | 273,105 | ​ | $ | 281,290 | ​ | $ | 275,311
Ireland | ​ |  | 42,333 | ​ |  | 40,749 | ​ |  | 39,863
Other foreign countries | ​ |  | 68,085 | ​ |  | 60,937 | ​ |  | 56,484
Total | ​ | $ | 383,523 | ​ | $ | 382,976 | ​ | $ | 371,658
Schedule of Segment Reporting Information, by Segment | Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the years ended December 31, 2023, 2022 and 2021, are as follows (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | 2023 |  | 2022 |  | 2021
Net sales | ​ | ​ |  |  | ​ |  |  | ​ |
Cardiovascular | ​ | $ | 1,220,560 | ​ | $ | 1,118,224 | ​ | $ | 1,043,227
Endoscopy | ​ |  | 36,806 | ​ |  | 32,757 | ​ |  | 31,524
Total net sales | ​ |  | 1,257,366 | ​ |  | 1,150,981 | ​ |  | 1,074,751
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Income from operations | ​ |  |  | ​ |  |  | ​ |  |
Cardiovascular | ​ |  | 114,440 | ​ |  | 80,946 | ​ |  | 53,415
Endoscopy | ​ |  | 9,504 | ​ |  | 6,617 | ​ |  | 7,501
Total income from operations | ​ |  | 123,944 | ​ |  | 87,563 | ​ |  | 60,916
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total other expense — net | ​ |  | (11,855) | ​ |  | (4,934) | ​ |  | (6,999)
Income tax expense | ​ |  | 17,678 | ​ |  | 8,113 | ​ |  | 5,463
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net income | ​ | $ | 94,411 | ​ | $ | 74,516 | ​ | $ | 48,454
Total depreciation and amortization by operating segment for the years ended December 31, 2023, 2022 and 2021, consisted of the following (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | 2023 |  | 2022 |  | 2021
Cardiovascular | ​ | $ | 88,960 | ​ | $ | 80,777 | ​ | $ | 83,000
Endoscopy | ​ |  | 1,025 | ​ |  | 1,027 | ​ |  | 1,066
Total | ​ | $ | 89,985 | ​ | $ | 81,804 | ​ | $ | 84,066
​ Total capital expenditures for property and equipment by operating segment for the years ended December 31, 2023, 2022 and 2021, consisted of the following (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | 2023 |  | 2022 |  | 2021
Cardiovascular | ​ | $ | 33,985 | ​ | $ | 44,925 | ​ | $ | 27,557
Endoscopy | ​ |  | 305 | ​ |  | 104 | ​ |  | 382
Total | ​ | $ | 34,290 | ​ | $ | 45,029 | ​ | $ | 27,939
​
Reconciliation of Assets from Segment to Consolidated | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | 2023 |  | 2022 |  | 2021
Net sales | ​ | ​ |  |  | ​ |  |  | ​ |
Cardiovascular | ​ | $ | 1,220,560 | ​ | $ | 1,118,224 | ​ | $ | 1,043,227
Endoscopy | ​ |  | 36,806 | ​ |  | 32,757 | ​ |  | 31,524
Total net sales | ​ |  | 1,257,366 | ​ |  | 1,150,981 | ​ |  | 1,074,751
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Income from operations | ​ |  |  | ​ |  |  | ​ |  |
Cardiovascular | ​ |  | 114,440 | ​ |  | 80,946 | ​ |  | 53,415
Endoscopy | ​ |  | 9,504 | ​ |  | 6,617 | ​ |  | 7,501
Total income from operations | ​ |  | 123,944 | ​ |  | 87,563 | ​ |  | 60,916
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total other expense — net | ​ |  | (11,855) | ​ |  | (4,934) | ​ |  | (6,999)
Income tax expense | ​ |  | 17,678 | ​ |  | 8,113 | ​ |  | 5,463
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net income | ​ | $ | 94,411 | ​ | $ | 74,516 | ​ | $ | 48,454

X
- Definition Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph b -SubTopic 10 -Topic 280 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration